Restraint of melanoma progression by cells in the local skin environment.

TitleRestraint of melanoma progression by cells in the local skin environment.
Publication TypeJournal Article
Year of Publication2024
AuthorsMa Y, Tagore M, Hunter MV, Huang T-H, Montal E, Weiss JM, White RM
JournalbioRxiv
Date Published2024 Aug 19
ISSN2692-8205
Abstract

Keratinocytes, the dominant cell type in the melanoma microenvironment during tumor initiation, exhibit diverse effects on melanoma progression. Using a zebrafish model of melanoma and human cell co-cultures, we observed that keratinocytes undergo an Epithelial-Mesenchymal Transition (EMT)-like transformation in the presence of melanoma, reminiscent of their behavior during wound healing. Surprisingly, overexpression of the EMT transcription factor Twist in keratinocytes led to improved overall survival in zebrafish melanoma models, despite no change in tumor initiation rates. This survival benefit was attributed to reduced melanoma invasion, as confirmed by human cell co-culture assays. Single-cell RNA-sequencing revealed a unique melanoma cell cluster in the Twist-overexpressing condition, exhibiting a more differentiated, less invasive phenotype. Further analysis nominated homotypic jam3b-jam3b and pgrn-sort1a interactions between Twist-overexpressing keratinocytes and melanoma cells as potential mediators of the invasive restraint. Our findings suggest that EMT in the tumor microenvironment (TME) may limit melanoma invasion through altered cell-cell interactions.

DOI10.1101/2024.08.15.608067
Alternate JournalbioRxiv
PubMed ID39229155
PubMed Central IDPMC11370352
Grant ListT32 GM152349 / GM / NIGMS NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
T32 GM008539 / GM / NIGMS NIH HHS / United States
R01 CA238317 / CA / NCI NIH HHS / United States
F30 CA236442 / CA / NCI NIH HHS / United States
K00 CA223016 / CA / NCI NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
F30 CA265124 / CA / NCI NIH HHS / United States
K99 CA266931 / CA / NCI NIH HHS / United States
R01 CA229215 / CA / NCI NIH HHS / United States
DP2 CA186572 / CA / NCI NIH HHS / United States